InspireMD
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InspireMD and other ETFs, options, and stocks.About NSPR
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions.
CEOMarvin L. Slosman
CEOMarvin L. Slosman
Employees86
Employees86
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2005
Founded2005
Employees86
Employees86
NSPR Key Statistics
Market cap69.06M
Market cap69.06M
Price-Earnings ratio-1.95
Price-Earnings ratio-1.95
Dividend yield—
Dividend yield—
Average volume33.95K
Average volume33.95K
High today$1.68
High today$1.68
Low today$1.62
Low today$1.62
Open price$1.63
Open price$1.63
Volume22.81K
Volume22.81K
52 Week high$3.34
52 Week high$3.34
52 Week low$1.51
52 Week low$1.51
Stock Snapshot
As of today, InspireMD(NSPR) shares are valued at $1.64. The company's market cap stands at 69.06M, with a P/E ratio of -1.95.
During the trading session on 2026-03-08, InspireMD(NSPR) shares reached a daily high of $1.68 and a low of $1.62. At a current price of $1.64, the stock is +1.2% higher than the low and still -2.4% under the high.
Trading volume for InspireMD(NSPR) stock has reached 22.81K, versus its average volume of 33.95K.
The stock's 52-week range extends from a low of $1.51 to a high of $3.34.
The stock's 52-week range extends from a low of $1.51 to a high of $3.34.
People also own
Based on the portfolios of people who own NSPR. This list is generated using Robinhood data, and it’s not a recommendation.